Application 203480
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | TABLET;ORAL | 625MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203480-001 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | 625MG | TABLET / ORAL | AB | 2018-05-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203480-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203480-001 | COLESEVELAM HYDROCHLORIDE | 625MG | TABLET / ORAL | AB | 2018-05-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203480-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | 845b8661-0aa9-418f-a496-df3d7a3130ff | 2026-01-29 | Warnings, Adverse reactions | 203480 ANDA203480 68462-433 |
| colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | A-S Medication Solutions | 67820d4f-0cfb-43ca-8974-08dffe474983 | 2024-11-18 | Warnings, Adverse reactions | 203480 ANDA203480 |
| colesevelam hydrochloride | COLESEVELAM HYDROCHLORIDE | A-S Medication Solutions | 79af88a5-b873-499b-a9a4-fc39624820fe | 2024-11-18 | Warnings, Adverse reactions | 203480 ANDA203480 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60687-621 | colesevelam hydrochloride | colesevelam hydrochloride | American Health Packaging | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-433 | colesevelam hydrochloride | colesevelam hydrochloride | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |